See more : Fortive Corporation (FTV-PA) Income Statement Analysis – Financial Results
Complete financial analysis of SAM HOLDINGS (9G2.SI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of SAM HOLDINGS, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Sino AG (XTP.F) Income Statement Analysis – Financial Results
- Chemplast Sanmar Limited (CHEMPLASTS.BO) Income Statement Analysis – Financial Results
- Concord Biotech Limited (CONCORDBIO.NS) Income Statement Analysis – Financial Results
- Leverage Shares 3x Alibaba ETC Securities (3BBE.L) Income Statement Analysis – Financial Results
- NovaGold Resources Inc. (NG.TO) Income Statement Analysis – Financial Results
SAM HOLDINGS (9G2.SI)
About SAM HOLDINGS
Singapore Institute of Advanced Medicine Holdings Ltd. operates as a holding company with interest in providing healthcare services. It offers pharmaceutical, surgical supplies and medical laboratory services. The company was founded by Djeng Shih Kien on November 24, 2011 and is headquartered in Singapore.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 16.65M | 16.23M | 13.81M | 12.92M |
| Cost of Revenue | 24.83M | 18.84M | 18.12M | 15.23M |
| Gross Profit | -8.19M | -2.60M | -4.31M | -2.32M |
| Gross Profit Ratio | -49.18% | -16.03% | -31.20% | -17.93% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 2.10M | 2.08M | 4.14M | 2.54M |
| Selling & Marketing | 10.96M | 8.07M | 319.64K | 207.68K |
| SG&A | 13.05M | 10.15M | 8.71M | 6.01M |
| Other Expenses | 0.00 | -1.70M | -1.50M | -1.14M |
| Operating Expenses | 13.05M | 11.85M | 10.21M | 7.15M |
| Cost & Expenses | 37.89M | 30.68M | 28.33M | 22.39M |
| Interest Income | 35.98K | 27.42K | 24.74K | 27.13K |
| Interest Expense | 11.55M | 2.42M | 1.20M | 1.19M |
| Depreciation & Amortization | 12.47M | 5.94M | 5.42M | 5.29M |
| EBITDA | -13.42M | -10.78M | -8.02M | -3.06M |
| EBITDA Ratio | -80.60% | -52.43% | -65.89% | -32.31% |
| Operating Income | -21.24M | -14.45M | -14.52M | -9.47M |
| Operating Income Ratio | -127.60% | -89.01% | -105.15% | -73.30% |
| Total Other Income/Expenses | -16.20M | -4.51M | -1.17M | -730.18K |
| Income Before Tax | -37.44M | -18.96M | -14.48M | -9.39M |
| Income Before Tax Ratio | -224.91% | -116.82% | -104.85% | -72.67% |
| Income Tax Expense | 0.00 | -892.64K | -2.05M | -37.52K |
| Net Income | -37.45M | -18.07M | -12.43M | -9.35M |
| Net Income Ratio | -224.95% | -111.32% | -89.98% | -72.38% |
| EPS | -0.04 | -0.06 | -0.04 | -0.04 |
| EPS Diluted | -0.04 | -0.06 | -0.04 | -0.04 |
| Weighted Avg Shares Out | 1.01B | 325.54M | 322.58M | 266.50M |
| Weighted Avg Shares Out (Dil) | 1.01B | 325.54M | 322.58M | 266.50M |
Source: https://incomestatements.info
Category: Stock Reports